Broomfield, Colorado--(Newsfile Corp. - October 9, 2025) - Aclarion, Inc. (NASDAQ: ACON) (NASDAQ: ACONW) ("Aclarion" or the "Company"), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today that it will be presenting at the 19th Annual Main Event on Monday, October 20, 2025 at 12:00 PM PT at the Hotel del Coronado in San Diego, CA. Jeff Thramann, Executive Chairman and Brent Ness, Chief Executive Officer will be giving the presentation.
To schedule a meeting with management, please email: This email address is being protected from spambots. You need JavaScript enabled to view it..
Event: LD Micro Main Event XIX
Date: Monday, October 20, 2025
Time: 12:00 PM PT
Register to watch the virtual presentation: https://ldmicrocasts.com/#register.
Summary of LD Micro Main Event XIX
The 2025 LD Micro Main Event XIX will run from October 19th to the 21st at the Hotel del Coronado in San Diego, California.
The first day will consist of registration, keynote speakers, and some gorgeous views of the Pacific. It will be followed by two full days of company presentations and one-on-one investor meetings concluded with a closing reception.
This three-day event will feature around 120 companies, presenting in half-hour increments, and attending private meetings with investors.
About Aclarion, Inc.
Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit www.aclarion.com.
About LD Micro
LD Micro is dedicated to being the definitive resource in the small-cap space. From its industry-recognized index and robust data to hosting some of the most influential events each year, LD Micro's mission is to provide unparalleled access and insight for those seeking the next generation of great companies.
To learn more about LD Micro, visit:
http://www.ldmicro.com
To learn more about Freedom US Markets LLC, visit:
https://www.freedomcapmkts.com
Investor Contacts:
Kirin M. Smith
PCG Advisory, Inc.
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Contacts:
Jessica Starman
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$8.71 |
| Daily Change: | -0.20 -2.24 |
| Daily Volume: | 13,340 |
| Market Cap: | US$5.070M |
October 01, 2025 September 25, 2025 June 10, 2025 | |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
